DD263291A5 - Verfahren zur herstellung eines unsymmetrischen, heterocyclischen ester-derivaten - Google Patents

Verfahren zur herstellung eines unsymmetrischen, heterocyclischen ester-derivaten Download PDF

Info

Publication number
DD263291A5
DD263291A5 DD87301364A DD30136487A DD263291A5 DD 263291 A5 DD263291 A5 DD 263291A5 DD 87301364 A DD87301364 A DD 87301364A DD 30136487 A DD30136487 A DD 30136487A DD 263291 A5 DD263291 A5 DD 263291A5
Authority
DD
German Democratic Republic
Prior art keywords
group
preparation
general formula
carbon atoms
formula
Prior art date
Application number
DD87301364A
Other languages
German (de)
English (en)
Inventor
Jacques Robin
Didier Pruneau
Francois Bellamy
Original Assignee
���K@��@����������@�������������@M�K�K�K�K]k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���K@��@����������@�������������@M�K�K�K�K]k�� filed Critical ���K@��@����������@�������������@M�K�K�K�K]k��
Publication of DD263291A5 publication Critical patent/DD263291A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Coloring (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Laminated Bodies (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD87301364A 1986-04-02 1987-04-01 Verfahren zur herstellung eines unsymmetrischen, heterocyclischen ester-derivaten DD263291A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8604685A FR2596760B1 (fr) 1986-04-02 1986-04-02 Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique

Publications (1)

Publication Number Publication Date
DD263291A5 true DD263291A5 (de) 1988-12-28

Family

ID=9333794

Family Applications (2)

Application Number Title Priority Date Filing Date
DD87301364A DD263291A5 (de) 1986-04-02 1987-04-01 Verfahren zur herstellung eines unsymmetrischen, heterocyclischen ester-derivaten
DD87325139A DD278793A5 (de) 1986-04-02 1987-04-01 Verfahren zur herstellung eines unsymmetrischen ester-derivates der 1,4-dihydropyridin-3,5-dicarbonsaeure

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD87325139A DD278793A5 (de) 1986-04-02 1987-04-01 Verfahren zur herstellung eines unsymmetrischen ester-derivates der 1,4-dihydropyridin-3,5-dicarbonsaeure

Country Status (25)

Country Link
US (2) US4806544A (cs)
EP (1) EP0240398B1 (cs)
JP (1) JPS6317883A (cs)
KR (1) KR900005956B1 (cs)
CN (1) CN1015460B (cs)
AT (1) ATE63555T1 (cs)
AU (2) AU590690B2 (cs)
CS (1) CS268828B2 (cs)
DD (2) DD263291A5 (cs)
DE (1) DE3770037D1 (cs)
DK (1) DK161787A (cs)
ES (1) ES2028886T3 (cs)
FI (1) FI86302C (cs)
FR (1) FR2596760B1 (cs)
GR (1) GR3002267T3 (cs)
HU (2) HUT53080A (cs)
IL (1) IL81933A (cs)
NO (1) NO167029C (cs)
NZ (1) NZ219758A (cs)
OA (1) OA08508A (cs)
PT (1) PT84560B (cs)
SU (1) SU1586515A3 (cs)
TN (1) TNSN87043A1 (cs)
YU (2) YU57287A (cs)
ZA (1) ZA872258B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4092406A1 (cs) * 1989-12-22 1993-04-01
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
WO1993006082A1 (en) * 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
EP2410854B1 (en) * 2009-03-27 2016-06-29 Council of Scientific & Industrial Research Substituted 1, 4-dioxa-8-azaspiro ý4,5¨decanes useful as fungicides and a process for the preparation thereof
WO2012123966A1 (en) 2011-03-04 2012-09-20 Arch Pharmalabs Limited Process for the preparation of 4 -substituted -1, 4-dihydropyridines
CN102796111B (zh) * 2012-09-10 2014-09-24 贵州大学 氧氮杂螺环酰胺基团的羧(磺)酸酯类化合物及制备方法和用途
CN104860873A (zh) * 2015-05-28 2015-08-26 石家庄学院 一种(s)-1,4-二氢吡啶钙离子拮抗剂的制备方法
CN108430989B (zh) * 2015-10-13 2021-10-08 轩竹生物科技有限公司 1,4-二氢吡啶-3,5-二羧酸酯衍生物的制备方法及中间体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
JPS4932542B1 (cs) * 1970-08-17 1974-08-31
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
US4250312A (en) * 1979-12-28 1981-02-10 Argus Chemical Corp. Process for preparing 4-piperidone spiroketal compounds
US4250313A (en) * 1980-02-01 1981-02-10 Argus Chemical Corp. Process for preparing 4-piperidone spiroketal compounds
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
WO1983003249A1 (fr) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical Derives de 1,4-dihydropyridine-3,5-dicarboxylate
JPS58159462A (ja) * 1982-03-17 1983-09-21 Yoshitomi Pharmaceut Ind Ltd 1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
EP0240398A1 (fr) 1987-10-07
YU44714B (en) 1990-12-31
AU610753B2 (en) 1991-05-23
FI86302B (fi) 1992-04-30
HUT49613A (en) 1989-10-30
DE3770037D1 (de) 1991-06-20
NZ219758A (en) 1989-04-26
YU57287A (en) 1988-10-31
NO167029C (no) 1991-09-25
YU48088A (en) 1988-12-31
PT84560B (pt) 1989-11-30
KR870010055A (ko) 1987-11-30
AU590690B2 (en) 1989-11-09
IL81933A0 (en) 1987-10-20
NO167029B (no) 1991-06-17
PT84560A (fr) 1987-04-01
DK161787A (da) 1987-10-03
IL81933A (en) 1991-06-30
SU1586515A3 (ru) 1990-08-15
ATE63555T1 (de) 1991-06-15
ES2028886T3 (es) 1992-07-16
HUT53080A (en) 1990-09-28
FR2596760B1 (fr) 1988-12-09
DK161787D0 (da) 1987-03-30
GR3002267T3 (en) 1992-12-30
KR900005956B1 (ko) 1990-08-18
FR2596760A1 (fr) 1987-10-09
CS229287A2 (en) 1989-08-14
US4900833A (en) 1990-02-13
CS268828B2 (en) 1990-04-11
FI871316A7 (fi) 1987-10-03
ZA872258B (en) 1987-11-25
NO871339D0 (no) 1987-03-31
EP0240398B1 (fr) 1991-05-15
TNSN87043A1 (fr) 1990-01-01
FI86302C (fi) 1992-08-10
US4806544A (en) 1989-02-21
HU199479B (en) 1990-02-28
AU7041087A (en) 1987-10-08
JPS6317883A (ja) 1988-01-25
OA08508A (fr) 1988-07-29
FI871316A0 (fi) 1987-03-25
AU4126389A (en) 1989-12-21
CN1015460B (zh) 1992-02-12
DD278793A5 (de) 1990-05-16
NO871339L (no) 1987-10-05
CN87102452A (zh) 1987-10-14

Similar Documents

Publication Publication Date Title
EP0002208B1 (de) Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung
EP0026317B1 (de) Optisch aktive 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0088276B1 (de) Neue Verbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0088274A1 (de) Neue 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihrer Verwendung in Arzneimitteln
EP0071819A1 (de) Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
EP0114270B1 (de) Acylderivate von 1,4:3,6-Dianhydro-hexiten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD263291A5 (de) Verfahren zur herstellung eines unsymmetrischen, heterocyclischen ester-derivaten
EP0039863A1 (de) 1,4-Dihydropyridine mit unterschiedlichen Substituenten in 2- und 6-Position, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3244178A1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0179386B1 (de) 1,4-Dihydropyridin-hydroxyamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE2549568C3 (de) 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
EP0157324A2 (de) Tetrahydrothienopyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0627427A1 (de) 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0218068A1 (de) Dihydropyridin-2-hydroxyamine, Verfahren zur Herstellung und ihre Verwendung in Arzneimitteln
EP0158956B1 (de) 4-(Nitrophenyl)-tetrahydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0362632A2 (de) Basische 4-Aryl-DHP-amide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0009560B1 (de) Neue 1,4-Dihydropyridazin-3-carbonylverbindungen, Verfahren zu ihrer Herstellung, die Verbindungen zur Verwendung bei der Behandlung von Krankheiten, diese enthaltende Arzneimittel und Verfahren zur Herstellung der Arzneimittel
DD242804A5 (de) Verfahren zur herstellung von dihydropyridinderivaten
DE4134760A1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1988007531A1 (en) New optically active compounds
DE3414802A1 (de) Hexahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0144847A2 (de) Hydroxy-tetrahydropyridinlactone, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
AT368494B (de) Verfahren zur herstellung von neuen nitrosubstituierten 1,4-dihydropyridinen
EP0393074A1 (de) Neue pyrrolidine
DE3821334A1 (de) 1,4-dihydropyridin-threonin-derivate, verfahren zu ihrer herstellung, zwischenprodukte und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee